12-Week-Combined Physical Training In Heart Failure Patients
NCT ID: NCT02571270
Last Updated: 2015-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: A longitudinal prospective study included 28 consecutive HFREF patients randomly divided in two age- and gender- matched groups: Trained Group (TG, n = 17), patients undergoing 12 weeks of supervised CPT and Non Trained Group (NTG, n = 11), patients receiving only medical prescription to practice regular physical exercise. All patients were submitted to clinical evaluation, transthoracic echocardiography, Cooper walk test and QL questionnaire before and after the study protocol. Student t test or Mann-Whitney test were performed for groups comparison and correlation tests for the same group variable associations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Training Effect in Patients With HF and PEF
NCT02696486
Effects of a Home-based Exercise Program on Functional Capacity and Quality of Life in Heart Failure Patients
NCT03615157
Exercise-based Cardiac Rehabilitation Program on Hospitalized Heart Failure Patients Submitted to Cardiac Transplantation
NCT03506737
Exercise Training in Patients With Heart Failure and Permanent Atrial Fibrillation
NCT03550872
High Intensity Interval Training Versus Moderate Continuous Training in Heart Failure With Preserved Ejection Fraction
NCT02916225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active lifestyle
Active lifestyle involves nutritional education, physical activity and active recreation.
Combined aerobic and resistance physical training program
Lifestyle counseling
Lifestyle counseling helps patients to have better self-care.
Combined aerobic and resistance physical training program
secondary prevention
Secondary prevention it is essential to prevent a new unfavorable event.
Combined aerobic and resistance physical training program
survival
The survival of patients with heart failure may increase with exercise training.
Combined aerobic and resistance physical training program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined aerobic and resistance physical training program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with optimized drug therapy;
* Age over 18 years.
Exclusion Criteria
* Decompensated HF in the last three months;
* Atrial fibrillation and/or implantable device at the moment of inclusion;
* Patients with chronic obstructive pulmonary disease (COPD);
* Patients with biomechanical limitations of physical activity.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual Paulista Júlio de Mesquita Filho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tainá Fabri
Master's degree
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UEPJMF-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.